Skip to main content
See every side of every news story
Published loading...Updated

Biocurious: Clever Culture seeks to snare the big fish in its global ‘land and expand’ strategy

Summary by Stockhead
Having signed up Astrazeneca as a foundation customer, the maker of an automated agar plate-monitoring device expects to land more big pharma ‘marlins’ Clever Culture’s APAS device prevents lab clean room contaminations – and expensive drug spoilage This year management is confident of at least matching its 2024-25 tally of 11 new installations   If you’re a small Adelaide-based medical device company, what’s better than having a large pharma co…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Stockhead broke the news on Tuesday, May 12, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal